Generic Aricept Approved for Alzheimer's Dementia

powered by healthline

Average Ratings

Tablets dissolve on the tongue

TUESDAY, Dec. 15 (HealthDay News) --Generic versions of the drug Aricept (donepezil hydrochloride) that will dissolve instantly on the tongue have been approved by the U.S. Food and Drug Administration to treat dementia resulting from Alzheimer's disease, the agency said Tuesday.

The newly approved tablets disintegrate rapidly, making it easier for elderly or disabled people to take them, the FDA said in a news release.

Alzheimer's is a progressive brain disease that slowly destroys memory and thinking, and, eventually, a person's ability to perform simple tasks. It's the most common cause of dementia among older people, although it is "not a normal part of aging," the FDA release said.

The generic versions of Aricept, to be available in 5 milligram and 10 milligram strengths, are to be produced by Philadelphia-based Mutual Pharmaceuticals.

More information

To learn more about this approval, visit the FDA.

-- Scott Roberts
Copyright © 2009 ScoutNews, LLC. All rights reserved.
Article from
Top of page
General Drug Tools
General Drug Tools view all tools
Tools for
Healthy Living
Tools for Healthy Living view all tools
Search Tools
Search Tools view all tools
Insurance Plan Tools
Insurance Plan Tools view all tools

What is a reference number?

When you register on this site, you are assigned a reference number. This number contains your profile information and helps UnitedHealthcare identify you when you come back to the site.

If you searched for a plan on this site in a previous session, you might already have a reference number. This number will contain any information you saved about plans and prescription drugs. To use that reference number, click on the "Change or view saved information" link below.

You can retrieve information from previous visits to this site, such as saved drug lists and Plan Selector information.